The TGF-β/ZEB2 axis plays an important role in drug resistance of GC, whereas miR-200C overexpression inhibits ZEB1/ZEB2, leading to sensitizing GC cells to trastuzumab (Zhou et al., 2018). This evidence concerns the gene ZEB1 and gastric cancer.